Dr. A. Eden Evins is the William Cox Family Professor of Psychiatry in the Field of Addiction Medicine at Harvard Medical School and founding director of the Center for Addiction Medicine and the Addiction Research Program of Massachusetts General Hospital (MGH). She is a member of the Schizophrenia Clinical and Research Program and the Depression Clinical and Research Program of MGH.
Dr. Evins earned her undergraduate degree at the University of
Virginia and her medical degree at the Medical University of South Carolina in Charleston. She completed an internship in Pediatric Medicine at the Children’s National Medical Center in Washington DC and her residency in psychiatry at Massachusetts Mental Health Center and Harvard-Longwood Psychiatry Residency Training Program in Boston, where she was also chief resident. She conducted a fellowship in molecular biology at the Mailman Research Center of McLean Hospital and a second fellowship in clinical and translational research at MGH with Dr. Don Goff. She received a Master’s in Public Health in Clinical Effectiveness from the Harvard School of Public Health.
Dr. Evins’ research interests include development of novel pharmacologic and behavioral treatments for nicotine dependence, cannabis dependence and for prevention of relapse to addictive disorders in those with and without co-occurring psychiatric illness. Her research pursuits include study of the cognitive effects of nicotine and of cannabis, and development pharmacotherapy for addictive disorders and for negative symptoms and cognitive dysfunction in schizophrenia. She has authored articles published in prestigious scientific journals, such as The Lancet, JAMA, JAMA Psychiatry, Biological Psychiatry, American Journal of Psychiatry, Neuropsychopharmacology, Addiction and the Journal of Clinical Psychiatry.
Dr. Evins has received three career awards from the National Institute on Drug Abuse (NIDA) of the National Institute of Health (NIH). She serves as a director of a Mass General based NIDA K12 Fellowship Training Program in Addiction Medicine. She is currently funded by grants from NIDA, NCI, NIMH, and PCORI.